Cargando…

Homogeneous Datasets of Triple Negative Breast Cancers Enable the Identification of Novel Prognostic and Predictive Signatures

BACKGROUND: Current prognostic gene signatures for breast cancer mainly reflect proliferation status and have limited value in triple-negative (TNBC) cancers. The identification of prognostic signatures from TNBC cohorts was limited in the past due to small sample sizes. METHODOLOGY/PRINCIPAL FINDIN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karn, Thomas, Pusztai, Lajos, Holtrich, Uwe, Iwamoto, Takayuki, Shiang, Christine Y., Schmidt, Marcus, Müller, Volkmar, Solbach, Christine, Gaetje, Regine, Hanker, Lars, Ahr, Andre, Liedtke, Cornelia, Ruckhäberle, Eugen, Kaufmann, Manfred, Rody, Achim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248403/ https://www.ncbi.nlm.nih.gov/pubmed/22220191 http://dx.doi.org/10.1371/journal.pone.0028403

Ejemplares similares

A clinically relevant gene signature in triple negative and basal-like breast cancer
por: Rody, Achim, et al.
Publicado: (2011)

T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers
por: Rody, Achim, et al.
Publicado: (2009)

Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer
por: Karn, Thomas, et al.
Publicado: (2014)

Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers
por: Bianchini, Giampaolo, et al.
Publicado: (2013)

Molecular profiling contributes more than routine histology and immonohistochemistry to breast cancer diagnostics
por: Shiang, Christine, et al.
Publicado: (2010)

Molecular differences between younger versus older ER-positive and HER2-negative breast cancers
por: Qing, Tao, et al.
Publicado: (2022)

Predicting prognosis of breast cancer with gene signatures: are we lost in a sea of data?
por: Iwamoto, Takayuki, et al.
Publicado: (2010)

Sphingosine-kinase-1 expression is associated with improved overall survival in high-grade serous ovarian cancer
por: Hanker, L. C., et al.
Publicado: (2021)

Dynamic classification using case-specific training cohorts outperforms static gene expression signatures in breast cancer
por: Győrffy, Balázs, et al.
Publicado: (2015)

Treatment of Recurrent Epithelial Ovarian Cancer
por: Claussen, Carlota, et al.
Publicado: (2020)

Post-Neoadjuvant Treatment in HER2-Positive Breast Cancer: Escalation and De-Escalation Strategies
por: Krawczyk, Natalia, et al.
Publicado: (2022)

Bayesian Mixture Models for Assessment of Gene Differential Behaviour and Prediction of pCR through the Integration of Copy Number and Gene Expression Data
por: Trentini, Filippo, et al.
Publicado: (2013)

Lack of sufficiently strong informative features limits the potential of gene expression analysis as predictive tool for many clinical classification problems
por: Hess, Kenneth R, et al.
Publicado: (2011)

Evaluation of biological pathways involved in chemotherapy response in breast cancer
por: Tordai, Attila, et al.
Publicado: (2008)

Primary ovarian leiomyoma: a rare ovarian tumour
por: Pervan, Mascha, et al.
Publicado: (2022)

Inhibitors of PD-1/PD-L1 and ERK1/2 impede the proliferation of receptor positive and triple-negative breast cancer cell lines
por: Bräutigam, Karen, et al.
Publicado: (2021)

Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer
por: Witzel, Isabell, et al.
Publicado: (2014)

Impact of lymphadenectomy on short- and long-term complications in patients with endometrial cancer
por: Proppe, Louisa, et al.
Publicado: (2022)

Gene expression profiling of breast cancer
por: Pusztai, Lajos
Publicado: (2009)

Clinical Relevance of Collagen Protein Degradation Markers C3M and C4M in the Serum of Breast Cancer Patients Treated with Neoadjuvant Therapy in the GeparQuinto Trial
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2019)

A prospective comparison of ER, PR, Ki67 and gene expression in paired sequential core biopsies of primary, untreated breast cancer
por: Hadad, Sirwan M., et al.
Publicado: (2016)

Bone metastasis-related signaling pathways in breast cancers stratified by estrogen receptor status
por: Hayashi, Naoki, et al.
Publicado: (2017)

Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer
por: Wali, Vikram B., et al.
Publicado: (2019)

Functional polymorphisms in cancer
por: Agarwal, Divyansh, et al.
Publicado: (2015)

PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer
por: Liedtke, Cornelia, et al.
Publicado: (2008)

Liver hyperplasia after tamoxifen induction of Myc in a transgenic medaka model
por: Menescal, Luciana A., et al.
Publicado: (2012)

4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017 : ABC4 Consensus: Assessment by a Panel of German Experts
por: Untch, Michael, et al.
Publicado: (2018)

EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
por: Leichsenring, Jonas, et al.
Publicado: (2022)

Fermentative α-Humulene Production from Homogenized Grass Clippings as a Growth Medium
por: Langsdorf, Alexander, et al.
Publicado: (2022)

Long-term satisfaction of patients after laparoscopic and robotic-assisted hysterectomy
por: Gitas, Georgios, et al.
Publicado: (2021)

Ink4a/Arf(−/−) and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f(−) quiescent cells
por: Kai, Kazuharu, et al.
Publicado: (2013)

The effects of a music intervention during port catheter placement on anxiety and stress
por: Schaal, Nora K., et al.
Publicado: (2021)

Is the (Neo)adjuvant Therapy of Patients with Primary HER2-positive Breast Cancer Cost-Covering?: Process Cost Analysis of Neoadjuvant and Post-Neoadjuvant Systemic Therapy of Patients with Primary HER2-positive Breast Cancer
por: Krawczyk, Natalia, et al.
Publicado: (2022)

Overexpression of the orphan nuclear receptor NR2F6 is associated with improved survival across molecular subgroups in endometrial cancer patients
por: Proppe, L., et al.
Publicado: (2023)

Correction to: TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer
por: Stürken, Christine, et al.
Publicado: (2021)

TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer
por: Stürken, Christine, et al.
Publicado: (2021)

AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022
por: Banys-Paluchowski, Maggie, et al.
Publicado: (2022)

Uptake of exemestane chemoprevention in postmenopausal women at increased risk for breast cancer
por: Aktas, Bilge, et al.
Publicado: (2016)

The Effect of the Degree of Homogenization on the Catalase Activity of Liver “Homogenates”
por: Adams, D. H., et al.
Publicado: (1957)

On homogeneous Lorentzian spaces whose null geodesics are homogeneous
por: Meessen, P
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_dvlqkc2elitv0p3na383o1fk07